Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China (mainland).
Department of Intensive Care Unit, Qingdao Municipal Hospital Group, Qingdao University, Qingdao, Shandong, China (mainland).
Ann Transplant. 2020 Dec 4;25:e926020. doi: 10.12659/AOT.926020.
BACKGROUND Liver transplant (LT) remains a life-saving procedure with a high mortality rate. The present study investigated the causes of death and sought to identify predictive factors of mortality during the initial LT hospitalization. MATERIAL AND METHODS We retrieved data on first-time adult recipients who underwent LT between November 2017 and October 2019 receiving grafts from donation after citizen's death. The risk factors for mortality during the initial LT hospitalization were confirmed by univariate analysis. We also analyzed the causes of death. RESULTS We enrolled 103 recipients, including 86 males and 17 females, with a mean age of 47.7 years. Thirty-eight (36.9%) recipients were labeled as non-cholestatic cirrhosis-related indications. Approximately 8% of all recipients had diabetes prior to LT. Induction therapy was used in 11 (10.7%) recipients, along with maintenance therapy. The median model for end-stage liver disease score at LT was 32.4 (21.4-38.4). The in-hospital mortality rate of LT recipients was 6.8% (7/103), and infections were responsible for most of the deaths (6/7). The 1 remaining death resulted from primary graft failure. Univariate analysis showed recipients with postoperative pneumonia (p2 mg/dL, and alanine transaminase on day 1 after LT >1800 µmol/L (all P<0.001) were much more likely to die. CONCLUSIONS In-hospital mortality of LT recipients was high, due in large part to infections. Acute hepatic necrosis, prolonged post-transplant ICU stays, certain types of postoperative infections, and postoperative liver and kidney dysfunction were potential risk factors for in-hospital mortality of LT recipients.
肝移植(LT)仍然是一种高死亡率的救命手术。本研究调查了死亡原因,并试图确定 LT 住院期间死亡的预测因素。
我们检索了 2017 年 11 月至 2019 年 10 月期间首次接受来自公民死后捐献的 LT 的成年受者的数据。通过单因素分析确认 LT 住院期间死亡的危险因素。我们还分析了死亡原因。
我们纳入了 103 名受者,包括 86 名男性和 17 名女性,平均年龄为 47.7 岁。38 名(36.9%)受者被标记为非胆汁淤积性与肝硬化相关的适应证。大约 8%的所有受者在 LT 前有糖尿病。11 名(10.7%)受者接受了诱导治疗,同时进行了维持治疗。LT 时终末期肝病模型评分中位数为 32.4(21.4-38.4)。LT 受者的住院死亡率为 6.8%(7/103),感染是导致大多数死亡的原因(6/7)。其余 1 例死亡是由于原发性移植物功能衰竭。单因素分析显示术后肺炎(p<0.001)、术后 1 天天冬氨酸转氨酶>1800 μmol/L(p<0.001)、总胆红素>2 mg/dL 和丙氨酸转氨酶>1800 μmol/L(均 p<0.001)的受者更有可能死亡。
LT 受者的住院死亡率较高,主要是由于感染。急性肝坏死、移植后 ICU 停留时间延长、某些类型的术后感染以及术后肝肾功能障碍是 LT 受者住院期间死亡的潜在危险因素。